APLT Applied Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: APLT

Price (delayed)

$2.42

Market cap

$186.89M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.18

Enterprise value

$149.97M

Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate, ...

Highlights
APLT's debt is down by 47% year-on-year and by 18% since the previous quarter
The company's EPS has surged by 64% YoY but it fell by 6% QoQ
The equity has dropped by 155% since the previous quarter
The quick ratio has declined by 34% year-on-year and by 11% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.appliedtherapeutics.com
Peers: OMGA

Key stats

What are the main financial stats of APLT
Market
Shares outstanding
77.23M
Market cap
$186.89M
Enterprise value
$149.97M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
20.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.07
Earnings
Revenue
$10.66M
EBIT
-$96.51M
EBITDA
-$96.05M
Free cash flow
-$54.06M
Per share
EPS
-$1.18
Free cash flow per share
-$0.6
Book value per share
-$0.17
Revenue per share
$0.12
TBVPS
$0.5
Balance sheet
Total assets
$45.2M
Total liabilities
$56.24M
Debt
$535,000
Equity
-$11.04M
Working capital
-$11.02M
Liquidity
Debt to equity
-0.05
Current ratio
0.8
Quick ratio
0.67
Net debt/EBITDA
0.38
Margins
EBITDA margin
-901.1%
Gross margin
100%
Net margin
-905.4%
Operating margin
-586.3%
Efficiency
Return on assets
-245.6%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
-905.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APLT stock price

How has the Applied Therapeutics stock price performed over time
Intraday
14.69%
1 week
30.81%
1 month
4.31%
1 year
154.74%
YTD
218.42%
QTD
-2.81%

Financial performance

How have Applied Therapeutics's revenue and profit performed over time
Revenue
$10.66M
Gross profit
$10.66M
Operating income
-$62.5M
Net income
-$96.51M
Gross margin
100%
Net margin
-905.4%
APLT's net margin is down by 32% since the previous quarter
The company's net income fell by 32% QoQ
Applied Therapeutics's operating income has increased by 31% YoY and by 6% from the previous quarter
The operating margin has increased by 6% from the previous quarter

Growth

What is Applied Therapeutics's growth rate over time

Valuation

What is Applied Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
20.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.07
The company's EPS has surged by 64% YoY but it fell by 6% QoQ
The equity has dropped by 155% since the previous quarter

Efficiency

How efficient is Applied Therapeutics business performance
The return on assets has dropped by 87% year-on-year and by 41% since the previous quarter
The company's return on sales fell by 32% QoQ

Dividends

What is APLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APLT.

Financial health

How did Applied Therapeutics financials performed over time
The company's total assets is 20% lower than its total liabilities
The quick ratio has declined by 34% year-on-year and by 11% since the previous quarter
The current ratio has contracted by 33% YoY and by 12% from the previous quarter
APLT's debt is 105% greater than its equity
The equity has dropped by 155% since the previous quarter
The company's debt to equity has shrunk by 150% YoY but it has surged by 67% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.